BioCentury
ARTICLE | Company News

Elusys, Pfizer deal

January 8, 2007 8:00 AM UTC

The companies partnered to develop infectious disease therapeutics using Elusys' Heteropolymer (HP) Antibody technology, which chemically links together two antibodies. The deal includes Elusys' ETI-...